Filter
2895
Filtered Results: 2895
Text search:
tb
strategy
Featured
Recommendations
242
New Publications
876
Language
Document type
No document type
1946
Studies & Reports
382
Guidelines
265
Strategic & Response Plan
115
Manuals
90
Fact sheets
33
Training Material
27
Situation Updates
19
Infographics
10
Resource Platforms
5
Brochures
2
Online Courses
1
Countries / Regions
India
147
Kenya
126
South Africa
103
Western and Central Europe
82
Uganda
77
Global
76
Ethiopia
75
Zambia
69
Nepal
68
Malawi
67
Tanzania
65
Nigeria
56
Africa
52
Namibia
52
Sierra Leone
51
Eastern Europe
51
Liberia
51
Rwanda
45
Bangladesh
43
Ghana
41
Myanmar / Burma
40
Lesotho
38
Indonesia
35
Ukraine
31
Cambodia
31
Latin America and the Carribbean
31
Philippines
28
Asia
26
Zimbabwe
24
South–East Asia Region
22
Botswana
21
Mozambique
14
East and Southern Africa
14
Colombia
13
Eswatini/ Swaziland
13
Senegal
12
Russia
12
South Sudan
12
Pakistan
11
Congo, Democratic Republic of
10
West and Central Africa
10
Benin
9
Syria
9
Haiti
8
Middle East and North Africa
8
Brazil
8
Albania
7
Burkina Faso
7
Tajikistan
6
Peru
6
Guinea
6
Venezuela
6
Southern Africa
6
Argentina
6
Georgia
6
Timor Leste/ East Timor
5
Thailand
5
Cameroon
5
Germany
5
Vietnam
5
Sudan
5
El Salvador
4
Laos
4
Afghanistan
4
Lebanon
4
Yemen
4
Somalia
4
Ecuador
4
Iran
3
Burundi
3
Armenia
3
Jordan
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Papua New Guinea
3
Sri Lanka
3
Central African Republic
3
Iraq
3
Estonia
2
USA
2
Saudi Arabia
2
Paraguay
2
North America
2
Bolivia
2
Moldova
2
Angola
2
Bhutan
2
Guatemala
2
North Macedonia
1
North Korea
1
Mexico
1
Serbia
1
Gambia
1
China
1
Chile
1
Singapore
1
Niger
1
Morocco
1
Qatar
1
Bulgaria
1
Hungary
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Maldives
1
Tunisia
1
Spain
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Poland
1
Honduras
1
Mali
1
Chad
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1383
Clinical Guidelines
175
Public Health
126
Women & Child Health
64
Key Resources
63
Capacity Building
35
Pharmacy & Technologies
26
Annual Report MEDBOX
2
Toolboxes
TB
540
HIV
403
AMR
114
COVID-19
109
Mental Health
55
NTDs
50
Caregiver
49
Pharmacy
41
Disability
38
NCDs
36
Global Health Education
36
Ebola
32
Health Financing Toolbox
31
Conflict
30
Rapid Response
26
Refugee
26
Polio
23
Planetary Health
21
Natural Hazards
16
Social Ethics
4
Specific Hazards
3
Cholera
3
Zika
2
South Sudan
1
Health Financing
1
This publication is part of WHO 75th anniversary and aims to capture key successes in public health globally and in Namibia. It includes contributory messages from the Head of State, Prime Minister and the Minister of Health and Social Services.
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Marco Schäferhoff and colleagues critique funding estimates for the maternal and child health Millennium Development Goals, and make recommendations for improving the tracking of financing flows and estimating the costs of scaling up interventions for mothers and children.
There is growing understanding and high-level endorsement of the importance of strong collaborative multisectoral approaches to address a broad range of social, economic and governance issues for the prevention and control of noncommunicable disease (NCDs) and mental health conditions. In 2019, Worl...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
This report shows that increased domestic revenues can and will cover only part of the necessary SDG budget spending of the LIDCs. Achieving the SDGs in the LIDCs will also require increases of both Official Development Assistance (ODA) and Private Development Assistance (PDA) to reach aggregate lev...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as asthma, osteoporosis, and diabetes, and offers guida...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. This article wants to determine the burden (prevalence,
mortality, and activity and work impairment) of severe asthma in 3 countries in East Africa: Uganda, Kenya, and Ethio...
Since there is no single objective diagnostic test for asthma this study suggests an approach of collecting and assembling pieces of clinical information to create a diagnostic picture, like making a jigsaw puzzle. These pieces should include demonstration of symptom and airway variability and/or br...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
